A Comparative Trial of Diazepam (Valium) and Amylobarbitone

Abstract

Short acting barbiturates such as amylobarbitone have long been the standby for relief of anxiety—certainly any new drugs introduced for the relief of such symptoms must stand comparison with these. Furthermore such symptoms are well known to be modifiable by such variables as the attitude of the doctor. For this reason a trial of such a new drug must be carried out under blind conditions.